Figures computed from official regulatory filings — .
Analysttarget 3 USD (-18%) · consensus 3/5 · 0 buy · 3 hold · 0 sell
Ownershipinsiders 6.34% · institutions 71.22% · short 11.9% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Quanterix Corp only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, the company offers contract research and clinical laboratory testing services, including research and clinical trial testing, and lucent diagnostic services. The company primarily operates in the areas of neurology, oncology and immunology, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and sales force and distributors. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
29 buys550 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Mendel Scott | Award | $15K | Unusual size | SEC |
| Magovcevic Ivana | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Magovcevic Ivana | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| DONNELLY WILLIAM Ptrack record | Award | $23.7K | SEC |
| Gute James Edward Jr. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Miller Michael Francis | Other | $68 | SEC |
| Miller Michael Francis | Other | $111.5 | SEC |
| Miller Michael Francis | Other | $301.9 | SEC |
| Miller Michael Francis | Other | $677.3 | SEC |
| Miller Michael Francis | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Miller Michael Francis | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Miller Michael Francis | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Miller Michael Francis | Other | $111.5 | SEC |
| Miller Michael Francis | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Miller Michael Francis | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Miller Michael Francis | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Miller Michael Francis | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Miller Michael Francis | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Miller Michael Francis | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Miller Michael Francis | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Miller Michael Francis | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Miller Michael Francis | Other | $128.2 | SEC |
| Miller Michael Francis | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Elliott Jeffrey Thomas | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Elliott Jeffrey Thomas | Exercise | n/a (No price was disclosed in the filing) | SEC |